Prognostic Stage III Breast Cancer AJCC v8 Completed Phase 1 / 2 Trials for Palbociclib (DB09073)

Also known as: Prognostic Stage 3 Breast Cancer AJCC v8

IndicationStatusPhase
DBCOND0109635 (Prognostic Stage III Breast Cancer AJCC v8)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03774472Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast CancerTreatment